KrimskyS. The role of theory in risk studies. In: KrimskySGoldingD, editors. Social theories of risk. Westport (CT): London; 1992. p. 3–22.
2.
NelkinD. The language of risk: conflicting perspectives on occupational health. Beverly Hills: Sage Publications; 1985. p. 200.
3.
LowiT. The end of liberalism. New York: Norton; 1979.
4.
WalkerJL. Mobilizing interest groups in America. Ann Arbor: University of Michigan Press; 1991.
5.
TrumanD. The governmental process. Berkeley: Institute of Governmental Studies Press; 1993.
6.
JasanoffSK. Is science socially constructed and can it still inform public policy?Sci Eng Ethics1996;2:263–76.
7.
WallackLDorfmanLJerniganDThembaM. Media advocacy and public health: power for prevention. Newbury Park (CA): Sage Publications; 1993.
8.
JasanoffS. The technical discourse of government. Cambridge (MA): Harvard University Press; 1995. p. 69–92.
9.
KingdonJW. Agendas, alternatives, and public policies. Boston: Little, Brown and Co.; 1984.
10.
MazmanianDSabatierP. Implementation and public policy. Lanham (MD): University Press of America; 1989.
11.
SabatierPA. Toward better theories of the policy process. Political Sci Process1991;147–56.
12.
StaynerL. Protecting public health in the face of uncertain risks: the example of diesel exhaust. Am J Public Health1999;89:991–3.
13.
OngEKGlantzSA. Constructing “Sound Science” and “Good Epidemiology”: tobacco, lawyers, and public relations firms. Tob Control2001;91:1–9.
14.
HirschhornNBialousS. Second-hand smoke and risk assessment: what was in it for the tobacco industry?Tob Control2001;10:375–82.
15.
BialousSYachD. Whose standard is it, anyway? how the tobacco industry determines the International Organization for Standardization (ISO) standards for tobacco products. Tob Control2001; 10:96–104.
16.
BeroL. Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health2003;24:267–88.
17.
GlantzSSladeJBeroLHanauerP. The cigarette papers. Berkeley: University of California Press; 1996.
18.
Roper Organization. A study of public attitudes towards cigarette smoking and the tobacco industry in 1978. Vol. 1. Roper Organization; 1978.
19.
BarnoyaJGlantzS. The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur J Public Health. In press.
20.
ChapmanS. Tobacco industry memo reveals passive smoking strategy. BMJ1997;314:1569.
21.
MuggliMEForsterJLHurtRDRepaceJL. The smoke you don't see: uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies. Am J Public Health2001;91:1419–23.
22.
LexchinJBeroLADjulbegovicBClarkO. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ2003;326:1167–70.
23.
BarnesDBeroL. Why review articles on the health effects of passive smoking reach different conclusions. JAMA1998;279:1566–70.
24.
BarnesDEBeroLA. Scientific quality of original research articles on environmental tobacco smoke. Tob Control1997;6:19–26.
25.
MaloneREBeroLA. Chasing the dollar: why scientists should decline tobacco industry funding. J Epidemiol Community Health2003;57:546–8.
26.
BeroLBarnesDHanauerPSladeJGlantzS. Lawyer control of the tobacco industry's external research program: the Brown and Williamson documents. JAMA1995;274:241–7.
27.
HanauerPSladeJBarnesDBeroLGlantzS. Lawyer control of internal scientific research to protect against products liability lawsuits: the Brown and Williamson documents. JAMA1995; 274:234–40.
28.
BarnesDBeroL. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Politics Policy Law1996;21:515–42.
29.
Center for Indoor Air Research. Request for applications: 1989–1990 research agenda. Center for Indoor Air Research; 1989.
30.
Center for Indoor Air Research. Center for Indoor Air Research 1992 research agenda and request for applications. Center for Indoor Air Research; 1992.
31.
Tobacco Institute. Tobacco smoke and the non-smoker: scientific integrity at the crossroads. Tobacco Institute; 1986.
32.
TurnerSCyrSGrossA. The measurement of environmental tobacco smoke in 585 office environments. Environ Int1992;18:19–28.
33.
HirschhornNBialousSAShatensteinS. Philip Morris' new scientific initiative: an analysis. Tob Control2001;10:247–52.
34.
BeroLAGalbraithARennieD. Sponsored symposia on environmental tobacco smoke. JAMA1994;271:612–7.
35.
BarnoyaJGlantzS. Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the “Latin Project.”Tob Control2002;11:305–14.
36.
National Research Council. Environmental tobacco smoke: measuring exposures and assessing health effects. Washington: National Academy Press; 1986.
37.
Department of Health and Human Services (US). The health consequences of involuntary smoking: a report of the Surgeon General. Washington: DHHS; 1986.
38.
SchotlandMSBeroLA. Evaluating public commentary and scientific evidence submitted in the development of a risk assessment. Risk Anal2002;22:131–40.
39.
ChapmanSBorlandRHillDOwenNWoodwardS. Why the tobacco industry fears the passive smoking issue. Int J Health Serv1990;20:417–27.
40.
BeroLAGlantzSA. Tobacco industry response to a risk assessment of environmental tobacco smoke. Tob Control1993;2:103–13.
41.
RJR Reynolds Tobacco Company. Passive smoking: an active controversy [advertisement], circa1993.
42.
RochonP. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journals. JAMA1994;272:108–13.
43.
ChoMKBeroLA. The quality of drug studies published in symposium proceedings. Ann Int Med1996;124:485–9.
44.
MontiniTBeroLA. Policy makers' perspectives on tobacco control advocates' roles in regulation development. Tob Control2001; 10:218–24.
45.
MontiniTMangurianCBeroLA. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland. Public Health Rep2002;117:291–8.
46.
DickersinKMinY-IMeinertCL. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA1992;267:374–8.
BeroLAGlantzSARennieD. Publication bias and and public health policy on environmental tobacco smoke. JAMA1994;272: 133–6.
49.
MisakianSBeroL. Publication bias and research on passive smoking. JAMA1998;280:250–3.
50.
BeroLRennieD. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA1995;274:1935–8.
51.
HongMKBeroLA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ2002;325:1413–6.
52.
SladeJBeroLHanauerPBarnesDGlantzS. Nicotine and addiction: the Brown and Williamson documents. JAMA1995; 274:225–33.
53.
BarnesDHanauerPSladeJBeroLGlantzS. Environmental tobacco smoke: the Brown and Williamson documents. JAMA1995;274:248–53.
54.
RennieD. Smoke and letters [editorial]. JAMA1993;270:1742–3.
55.
RaymondCA. Risk in the press: conflicting journalistic ideologies. In: NelkinD. The language of risk. Beverly Hills (CA): Sage Publications; 1985. p. 87–132.
56.
KennedyGBeroL. Print media coverage of research on passive smoking. Tob Control1999;8:254–60.
57.
MaloneRBoydEBeroL. Science in the news: journalists' constructions of passive smoking as a social problem. Soc Stud Sci2001;30:713–35.
58.
RothALDunsbyJBeroLA. Framing processes in public commentary on US federal tobacco control regulation. Soc Stud Sci2003;33:7–44.
59.
BeroLAMontiniTBryan-JonesKMangurianC. Science in regulatory policy making: case studies in the development of workplace smoking restrictions. Tob Control2001;10:329–36.
60.
Bryan-JonesKBeroL. Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule. Am J Public Health2003;93:585–92.
61.
JasanoffS. EPA's regulation of daminozide: unscrambling the messages of risk. Sci Technol Hum Values1987;12:116–24.
62.
SilbergeldE. Risk assessment: the perspective and experience of U.S. environmentalists. Environ Health Perspect1993;101:100–4.
63.
WilsonJQ. Bureaucracy: what government agencies do and why they do it. Baltimore: Johns Hopkins University Press; 1989.
64.
Environmental Protection Agency (US). Respiratory health effects of passive smoking: lung cancer and other disorders. Washington: EPA, Office of Research and Development, Office of Health and Environmental Assessment; 1992.
65.
California Environmental Protection Agency. Health effects of exposure to environmental tobacco smoke. Sacramento: California Environmental Protection Agency; 1997.
66.
MangurianCBeroL. Lessons learned from the tobacco industry's efforts to prevent the passage of a workplace smoking regulation. Am J Public Health2000;90:1926–30.
67.
HirayamaT. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. BMJ1981;282:183–5.
68.
LeePN. “Marriage to a smoker” may not be a valid marker of exposure in studies relating environmental tobacco smoke to risk of lung cancer in Japanese non-smoking women. Int Arch Occup Environ Health1995;67:287–94.
69.
BekelmanJLiYGrossC. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA2003;289:454–65.
70.
BeroLARennieD. Influences on the quality of published drug studies. Int J Technol Assess Health Care1996;12:209–37.
71.
NestleM. Food politics: how the food industry influences nutrition and health. Berkeley: University of California Press; 2002.
72.
LevineJGussowJHastingsDEccherA. Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am J Public Health2003; 93:664–9.
73.
MarkowitzGRosnerD. Deadly dust: silicosis and the politics of occupational disease in twentieth century America. Princeton (NJ): Princeton University Press; 1991.
74.
MarkowitzGRosnerD. “Cater to the children”: the role of the lead industry in a public health tragedy, 1900–1955. Am J Public Health2000;90:36–46.
75.
MarkowitzGRosnerD. Deceit and denial: the deadly politics of industrial pollution. Berkeley: University of California Press; 2002.
76.
BoydEBeroL. Assessing faculty financial relationships with industry. JAMA2000;284:2209–38.
77.
von WinterfeldtD. Expert knowledge and public values in risk management: the role of decision analysis. In: KrimskySGoldingD, editors. Social theories of risk. Westport (CT): London; 1992. p. 321–42.
78.
ChoM. Fundamental conflict of interest. BioMedNet Magazine1998;24.
79.
KrimskyS. Science in the private interest. Lanham (MD): Rowman & Littlefield Publishers, Inc.; 2003.
80.
DanaJ. Harm avoidance and financial conflict of interest. Pittsburgh: Carnegie Bosch Institute; 2003. p. 1–18.
ShamooAEResnikDB. Responsible conduct of research. New York: Oxford University Press; 2003.
83.
BoydEAChoMKBeroLA. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med2003;78:769–74.
84.
HermanR. Harvard School of Public Health faculty votes not to accept funds from the tobacco companies and subsidiaries [press release]. Boston: Harvard School of Public Health; 2002. p. 1–2.
85.
ShieldM. Policies and positions of other organizations on the funding controversy. TRDRP Newsletter. Burning Issues2001;4:2–4.
86.
CohenJ. Accepting tobacco funding for research: an overview of the issues. TRDRP Newsletter Burning Issues2003;6:7–10.